Occupational risk factors in inflammatory bowel disease by Leso, V et al.
2838
Abstract. – OBJECTIVE: Crohn’s disease and
ulcerative colitis are the two main forms of in-
flammatory bowel disease (IBD). Although the
aetiology of IBD is not completely understood,
an interaction between genetic and environmen-
tal factors has been proposed. In this context,
however, environmental epidemiology lacks a
comprehensive evaluation of the possible role of
occupational exposures in IBD development and
progression. Therefore, aim of our review was to
evaluate how certain occupational risk factors
may affect IBD pathogenesis, clinical history and
severity of disease manifestations.
MATERIALS AND METHODS: A critical revi-
sion of available literature concerning exposure
to groups of potential workplace hazardous
agents and IBD, as it appears in Medline and
Web of knowledge, was performed.
RESULTS: The role of workplace exposures to
chemical and biological agents, ionizing or non-
ionizing radiations, shift-works, indoor, and
sedentary works as well as job strain on IBD has
been critically revised. However, the limited num-
ber of studies addressing these issues prevented
us from extrapolating definite conclusions.
CONCLUSIONS: Our review pointed out some
critical aspects concerning the relationship be-
tween occupational factors and IBD, in terms of
causative pathways, hazardous exposure, sus-
ceptibility and consequences of IBD functional
limitations on career choice and fitness for work
that need future investigations. Overall, this
seems a challenging public health issue, consid-
ering the strong IBD impact on patients’ quality
of life, work productivity and costs to society.
Moreover, this review may encourage concert-
ed actions of health care specialists, occupa-
tional physicians, employers and IBD workers to
plan preventive and protective measures for
“healthier patterns of work” for IBD and to devel-
op innovative perspectives for an integrated
management of “IBD at work”.
Key Words:
Inflammatory bowel disease, Crohn’s disease, Ulcer-
ative colitis, Occupational risk factors; Workplace haz-
ardous agents, Biological and physical agents, Chemi-
cals, Organizational aspects, Ability to work, Inflam-
matory bowel disease management.
European Review for Medical and Pharmacological Sciences
Occupational risk factors in
inflammatory bowel disease
V. LESO, W. RICCIARDI, I. IAVICOLI
Institute of Public Health, Catholic University of the Sacred Heart, School of Medicine, Rome, Italy
Corresponding Author: Veruscka Leso, MD; e-mail: veruscka@email.it
Introduction
Crohn’s disease (CD) and ulcerative colitis
(UC) are the two main forms of inflammatory
bowel disease (IBD). CD is a relapsing systemic
illness, mainly affecting the gastrointestinal tract,
that frequently presents with abdominal pain,
fever, and clinical signs of bowel obstruction or
diarrhoea with passage of blood and/or mucus1.
UC is characterized by a chronic inflammation
restricted to the mucosal surface which starts in
the rectum and generally extends proximally in a
continuous manner through the entire colon.
Bloody diarrhoea is the characteristic symptom
of the disease2. The incidence and prevalence of
IBD are increasing with time and in different re-
gions around the world, indicating its emergence
as a global disease3. The highest annual inci-
dence per 100000 person-years for UC and CD
was estimated in 24.3 and 12.7 in Europe, 19.2
and 20.2 in North America, respectively. Compa-
rably, the highest reported prevalence values for
IBD were in Europe (UC, 505 per 100000 per-
sons; CD, 322 per 100000 persons) and North
America (UC, 249 per 100000 persons; CD, 319
per 100000 persons). Although increasing, rates
were lower in the southern hemisphere and east-
ern countries4. Age stratification showed a peak
in IBD incidence rates in the second to fourth
decade, with the highest incidence among 20-29
years old, while a second modest rise was report-
ed in latter decades of life, 60-70 years3,4.
The etiology of IBD has been extensively
studied in the past few decades, although the dis-
ease pathogenesis is not yet fully understood5. It
is widely considered that IBD occurs due to a
disturbed innate and adaptive immune response
towards a diminished diversity of commensal mi-
crobiota in genetically predisposed subjects trig-
gered by environmental influences6,7. Environ-
mental factors, in fact, are essential components
of the pathogenesis of IBD and primarily respon-
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sible for its growing incidence around the globe.
Epidemiological, clinical and experimental evi-
dences support an association between IBD and a
large number of seemingly unrelated environ-
mental factors, which include smoking, diet,
drugs, geographical and social status, stress, mi-
crobial agents, intestinal permeability and appen-
dectomy8,9.
Unfortunately, in the environmental epidemiol-
ogy of IBD, a deep analysis of the possible role of
potentially “longlife” occupational exposures in
affecting the development, clinical history and
severity of IBD manifestations, is still lacking.
Only few earlier socio-economical studies, in fact,
suggested that IBD tended to affect the higher so-
cial classes more frequently than the lower ones,
as well as the white collar employees more than
blue collars, with IBD patients more likely to be
employed in professional, managerial, skilled
labour positions10-18. Overall, this socioeconom-
ic/occupational distribution may be explained by
an increased workplace exposure to a distinct set
of environmental triggers which could act as pos-
sible risk factors for the occurrence and exacerba-
tion of IBD. The definition of such risk factors
may, in fact, give an insight into the yet unknown
etiology of the disease. At the same time, it is
worth considering that IBD imposes patients prac-
tical restrictions to their working lives leading to
choose certain job occupations, as well as requir-
ing great efforts to maintain job and to daily face
work-related risks and problems.
Therefore, the present review aims to give a
comprehensive evaluation of the possible rela-
tionship between exposure to specific occupa-
tional risk factors and IBD. This may provide
valuable insights into the role of certain job fac-
tors and the mechanisms that contribute to the
occurrence and progression of IBD in order to
define issues for future epidemiologic research. It
may be extremely important also from a public
health perspective, considering the increasing
global burden of IBD and its strong and lifelong
impact on the patient’s quality of life and work
productivity as well as on health care resources.
Lastly, this review may give a stimulus to de-
velop innovative perspectives for a global/inte-
grated IBD management, providing also health
care specialists, occupational physicians and em-
ployers additional information to plan and adopt
adequate preventive measures to protect IBD
workers, and to give them efficient support to
face occupational risks to which they may be
more susceptible.
Materials and Methods
Aim of this review was to overcome the quite
fragmented knowledge concerning the socio-eco-
nomical stratification of CD and UC patients to-
ward a more accurate comprehension of the IBD
occupational distribution according to the “type
of environment” in which they work19. We con-
ducted a systematic search of articles, published
in Medline and ISI Web of knowledge up to De-
cember 2014, regarding occupational risk factors
potentially related to the development and pro-
gression of IBD.
Although we carried out a preliminary Med-
line search for the terms “inflammatory bowel
disease” and “occupational risk factors”, only 26
references were retrieved. Out of these, only 9
were considered suitable for our scope by title
and abstract screening. Therefore, we extended
our research including the following keywords as
free terms in the electronic search: “inflammato-
ry bowel disease”, “Crohn’s disease”, “Ulcerative
colitis”, which were individually combined with
the operator “AND” with the terms related to the
major subject of “exposure to workplace haz-
ardous agents”, such as “occupation* OR work*
OR workplace OR job exposure”, “chemicals”,
“metals”, “biological agents”, “bacteria”, “physi-
cal factors”, “physical workload OR activity”,
“magnetic field”, “ionizing radiation exposure”,
“ultraviolet exposure”, “shift-work”, “night-
work”, “work related stress”, “job strain”.
In this formative phase of knowledge, the
search strategy was intended to be broad in or-
der to maximize the capture of citations of peer-
reviewed English publications including re-
views, articles, letters and commentaries rele-
vant to extrapolate useful data to understand the
role of occupational risk factors for IBD epi-
demiology. All fulltexts of the papers consid-
ered valuable for the aim of our review were ob-
tained and a critical evaluation performed. Cita-
tion pool of relevant publications identified in
the literature search was further supplemented
through the manual assessment of the reference
list accompanying published papers for other
potentially eligible articles.
Results
Potential workplace hazardous agents identi-
fied have been grouped in common risk factors
categories in order to clearly define the complex
2840
V. Leso, W. Ricciardi, I. Iavicoli
interplay between occupational risk factors and
IBD manifestations, in particular workplace sce-
narios as well as the relationship between IBD
morbidity and ability to face specific risk factors.
Chemical Risk Factors
The possible causative role of chemical expo-
sure in IBD development has been suggested by
a series of occupations associated with an in-
creased risk of disease. Instrument makers, elec-
tricians, persons in health-related occupations,
and hairdressers were reported to have an higher
prevalence of IBD by Sonnenberg20. Li et al21
found men employed as drivers, textile, glass, ce-
ramic and tile workers, chemical process,
smelters and metal foundry workers to be at in-
creased risk of hospitalization for CD and UC in
an economically active Swedish population.
Comparable results were reported for women
employed as mechanics, printers, iron and metal-
ware, wood and related workers21. According to
the Authors21, these occupations were character-
ized by a variable degree of chemical exposure.
Unfortunately, only job title was used to assess
the association between occupation and proximi-
ty to specific agents, therefore, it was not feasible
to identify the kinds of agents that may be in-
volved in the casual pathways.
For many years, exposure to xenobiotic like
metals have been suggested to induce an immune
response in different diseases including autoim-
mune diseases22. Aluminum (Al) was firstly sug-
gested as an environmental exposure factor pos-
sibly involved in the pathogenesis and/or main-
taining of CD23. Exposures to Al dusts and fumes
are among occupational hazards of workers in
the Al refining and metal industry, printing and
publishing, and automotive dealerships and ser-
vices. Al immune effects share domains with the
immune pathology of CD such as the activation
of antigen presenting cells, the induction of a T-
helper (Th-1) inflammatory response exerted by
luminal bacteria or dietary compound adsorbed
to the metal, the enhancement of pro-inflamma-
tory, apoptotic and oxidative stress molecule ex-
pression, the transmural granuloma formation as
well as the induction of colitis in a CD animal
model22-24. It is possible that barrier permeability
abnormalities, due to epithelial tight junction dis-
ruption and restitution arrest, gross mucosal le-
sions, or defective functioning of Peyer’s patches
or M (Microfold cells) epithelium, described in
CD, may operate in concert to increase the toxic-
ity of nano-microparticles containing Al, thus, in-
ducing or aggravating the disease25,26. Pearl et al27
put forward the hypothesis that, due to bacterial-
metal interaction, Al and other metals can play a
role in CD induction. The Al uptake by certain
microbial organisms, in particular mycobacterial
species, may alter the pathogenicity of these or-
ganisms and exacerbate the host’s responses to
them inducing a prominent granulomatous im-
mune response, therefore, giving rise to the
pathologic features of CD.
A single case report of an electrician with recur-
rent exacerbations of UC associated with industri-
al mercury vapour exposure suggested the role of
this metal in UC reactivation28. Symptoms began
within 24 hours after he performed maintenance
services upon mercury filled electrical blocks in
an electroplating plant for one full-workday. The
timing of the recurrent reactivations, suggested
that occupational over-exposure to mercury
vapour may lead to a disease relapse hypothetical-
ly due to an increased adsorption of ingested mer-
cury through the UC abnormal mucosa. Unfortu-
nately, the lack of subsequent confirming data
does not allow to support a causative role of this
kind of chemical in UC re-activation.
The perfluorooctanoic acid (PFOA), a sub-
stance widely employed in the manufacture of a
variety of consumer products, such as Gore-tex
and Teflon29 and able to affect the immune re-
sponses in in vivo experiments30,31 has been in-
vestigated as an influencing factor in IBD inci-
dence32. A PFOA exposed Mid Ohio Valley com-
munity population living and working in contam-
inated water districts and a cohort of exposed
workers employed at the DuPont chemical plant
between 1948 and 2002 have been studied33. Me-
dian PFOA serum levels for community residents
was estimated in 24 ng/ml while it was 113
ng/ml for workers. UC, but not CD, showed a
significant positive association with cumulative
PFOA exposure with adjusted rate ratios (RR)
ranging from 1.76 to 2.86 for all three upper
quartiles versus the lowest quartile (RR:1.00) of
estimated cumulative exposure. Plausible mecha-
nisms linking PFOA and UC, extrapolated by ex-
perimental findings, may include shifts in the
balance of tissue macrophages towards an anti-
inflammatory phenotype and/or a Th-2-like re-
sponse to specific antigens suggesting a general
increase in host susceptibility to infections34.
Biological Risk Factors
Infectious agents are thought to be involved in
the pathogenesis and clinical course of IBD ei-
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ther through the colonization of the inflamed mu-
cosa of IBD patients as secondary invaders or in-
nocent bystanders, or via the direct induction of
the disease35. Since the first description of the
similarities between CD and Johne’s disease (JD)
in cattle36, it has been argued that Mycobacterium
avium subspecies Paratuberculosis (MAP),
which causes JD, might also act as a causal fac-
tor in CD37. As a confirmation, the conclusion of
a recent meta-analysis seemed to indicate an as-
sociation between MAP and CD38. However, the
establishment of this association is controversial,
since critics of the mycobacterial theory argue
that MAP is a secondary invader rather than a
causal factor39.
To further explore the hypothesis that occupa-
tional exposure to MAP, through MAP-infected
cattle or dairy products, increases risk for CD, a
cross-sectional study was conducted to obtain in-
formation on the occurrence of CD in U.S. dairy
and beef cattle producers (n. 702) and veterinari-
ans (n. 774)40. Fifty nine, 71% and 42% of veteri-
narians, dairy and beef producers, respectively,
reported contact with cattle with confirmed cases
of JD. There were 3 CD cases in producers and 4
in veterinarians. Importantly, no association was
found between exposure to JD and the occur-
rence of CD, therefore, no association was
demonstrated between CD and MAP. Compara-
bly, a study carried out on dairy farmers from
United Kingdom detected a CD prevalence in
these workers not different from that in the gen-
eral population and failed to find an association
between exposure to clinical cases of JD and the
development of CD or UC41. However, the small
number of IBD cases limits the power of these
studies to detect important differences40,41.
It has been suggested that hypersensitivity to
baker’s yeast, Saccharomyces cerevisiae, or re-
lated antigens may play a role in CD, as these
patients demonstrated IgA and IgG titres to this
yeast significantly higher than controls42-44.
Strains of this organism are used in baking and
brewing and are found in a wide variety of
foodstuffs, and could explain the ubiquitous oc-
currence of CD. Evidence for the involvement
of baker’s yeast in CD has been reported by
Sonnenberg20,45 investigating the occupational
distribution of CD prevalence and mortality46.
As regards this latter issue, analyses of occupa-
tional mortality from CD in England and
Wales45 have shown a proportional mortality ra-
tio (between observed and expected value)
close to 3.5 times greater for bakers than the
one for managers in retail (who had the second
highest ratio of all professions). These findings
were further supported by the social security
statistics from West Germany showing that,
among all professions in men, bakers had the
highest odds ratio for CD20.
Finally, with respect to biological risk for
healthcare workers, a first study carried out on
British nurses with IBD, failed to identify the
regular assistance to IBD patients as a biological
risk factor for the development of the disease, al-
though they manifested IBD at an earlier age
compared to the members of the community47.
Subsequent studies reported conflicting results
for IBD risk in health care professions which re-
sulted at increased risk in Sonnenberg20 while at
decreased risk in Li et al21. Therefore, the defini-
tion of biological risk factors for inflammatory
gastrointestinal disorders needs to be deeply de-
fined.
Physical Risk Factors
Limited attention has been paid to the possi-
ble association between exposure to physical
agents in the workplace, such as ionizing and
non-ionizing radiation, and IBD also in compli-
cated forms. As concerns the potential effects of
radiation exposure on IBD, there is no a strong
literature concerning the potential synergy be-
tween radiation and UC in developing colon
cancer which is a recognised risk for IBD pa-
tients48. Several factors have been associated
with an increased risk of colorectal cancer in
IBD patients with duration and extensive dis-
ease, a family history of sporadic colorectal
cancer, uncontrolled inflammation, shortened
colon, and multiple pseudopolyps as the most
important1,2,49. In this context, only one paper,
from an occupational health perspective, stated
that an x-ray technician affected by UC should
not be at increased risk of any type of cancer if
all the proper preventive and protective proce-
dures are followed, if modern x-ray equipment
is used to prevent the dispersion of the x-rays
and if appropriate shielding apron is worn to
protect the entire colon. Certainly, a continuous,
close medical follow-up is strongly recommend-
ed50. However, it is a complex issue considering
also that the standard management of IBD pa-
tients actually includes performing repeated
imaging tests using ionizing radiation which
may have a cumulative effect on the patients
and increase their own risk of malignancy in the
long term51,52.
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Concerning electro-magnetic fields, a single
occupational case report described the onset of
thyroiditis and IBD following a prolonged and
intense exposure to 50 Hz magnetic fields53. The
patient was a manager, employed in a shopping
centre for 7 years exposed to a chronic daily
over-exposure of magnetic field due to her office
location immediately above the 50 Hz substation
for the centre and three busbars carrying high
current. The magnetic field from the substation
was found to be 1000-1400 mG at 0.5 m above
the floor where her chair was placed, and up to
3400 mG at floor level with an Australian public
exposure limit of 1000 mG54. The Author sug-
gested that the chronic daily overexposures could
have stimulated the smooth muscle or myenteric
plexus of her gastrointestinal tract contributing to
the development of IBD. Tuncel et al55 have
shown that a chronic exposure to 5 mT (50 000
mG) of 50 Hz electromagnetic fields can affect
cytoplasmic E-cadherin expression and weaken
cell adhesion mechanisms in a rat colon tumour
model. This may have caused a ‘leaky’ bowel
mucosa, permitting the entrance of foreign anti-
gens, which may be a pathogenic pathway in
IBD inducing also an immune cross-reaction to
the thyroid53. Conversely to the “pro-inflammato-
ry” effects reported by Hocking53, a pulsating
electromagnetic field (50 Hz with a flux density
of 45 mT for three hours/day with 24 h intervals)
induced a significant reduction in cell viability, a
decrease in interferon-γ production as well as an
increase in interleukin (IL)-10 release in periph-
eral blood mononuclear cells isolated from non-
treated CD patients compared to unexposed con-
trols, supporting a potential role of the electro-
magnetic field therapy in IBD treatment56.
Interestingly, certain job characteristics such
as exposure to open air might be protective
against developing IBD. This is because individ-
uals who work outdoor receive more sun expo-
sure, thus more ultraviolet exposure, with a
greater synthesis of vitamin D. This may explain
why farmers and agricultural production of live-
stock resulted among the occupations and indus-
tries, respectively, with the lower proportional
IBD mortality ratio, as retrieved from compu-
tized 1991-1996 data files of the US National
Center for Health Statistics. Conversely, IBD
mortality was increased, although in a not signifi-
cant manner, in occupations associated with in-
door work, i.e. sales persons, secretaries and ad-
ministrative personnel18. However, a correct in-
terpretation of these data requires to consider that
the occupations recorded at the time of death fre-
quently reflected only the period of last or
longest employment, with other employments
going unnoticed. Moreover, IBD mortality may
seem artificially low among occupations that at-
tracted expecially healthy persons, inducing a po-
tential selection bias in the data evaluation18.
However, the beneficial effects of sun expo-
sure on IBD were confirmed by North-South gra-
dients in CD rates described in Europe and in
North-America: they reveal how environments
with southern exposures, which receive more
sunlight and translate into spending more time
outdoors, are associated with a lower prevalence
of disease19,57-59. As concerns the relationship be-
tween UV exposure and IBD severity, lower ul-
traviolet exposure was also associated with
greater rates of hospitalization, prolonged hospi-
talization and the need for bowel surgery60. As
UV exposure is a strong determinant of vitamin
D status, the observed effects of UV exposure on
IBD hospitalization and severity may be mediat-
ed by vitamin D61. In fact, in vitro and in vivo da-
ta have demonstrated vitamin D to possess im-
munomodulatory properties through several
mechanisms such as diminished inflammatory
response to antigenic stimulation, down-regula-
tion of the expression of pro-inflammatory cy-
tokines in favour of anti-inflammatory proteins
and the shift from a Th-1, Th-17 profile to Th-2
and regulatory T cells61.
Physical Workload
Shifting workforce proportion to sedentary oc-
cupations and technology developments in tradi-
tionally physically demanding occupations have
resulted in low physical workloads for many
workers. Insufficient physical stress is known to
result in reduced bone density, muscular strength
and endurance, impaired neuromuscular coordi-
nation and cardiovascular fitness and deteriora-
tion in mood and psychological state62.
As regards the effects of physical activity on
IBD, Sonnenberg20, using occupation as a proxy,
described an inverse correlation between occupa-
tions involving exercise and risk of CD and UC,
supporting the thesis that having to exercise
seems to be a protective working condition. In
fact, the occurrence of IBD was low among
workers in building and construction, unskilled
labourers, machinists and transport men as well
as in housekeepers, cleaning and maintenance
workers. Comparably, IBD mortality was low
among blue collar workers and high among white
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collar ones, which demonstrates the protective
influences associated with physically demanding
occupations63. Particularly, a lower mortality rate
was reported in occupations associated with
manual work, i.e. among farming occupations,
manufacturing occupations, and manual labour-
ers, while a greater rate was described in seden-
tary works such as among sales persons, secre-
taries, managerial occupations and teachers18,63.
As an ulterior confirmation, a sedentary job
has been suggested as a plausible risk factor for
IBD given that abdominal transit time may in-
crease in persons with sedentary jobs, therefore
allowing more time for immunologic reactions to
dietary and bacterial antigens to take place in the
intestine64. An epidemiology study on soldiers
with UC in American Army65 showed that there
was a significantly greater occurrence of the dis-
ease among white officers than among white en-
listed men. Evaluated on the basis of occupation
within the military service, a significant prepon-
derance was found among men who had previ-
ously been engaged in trade, and a minor repre-
sentation among men who had previously been
involved in agriculture. Furthermore, data from
the population-based study by Bernstein et al16
found that individuals with IBD were twice as
likely to have sedentary jobs. This was in line
with previous findings by Boggild et al64 who
found that female office workers had a greater
risk of hospital admission for IBD and with those
by Li et al21 who reported a significantly in-
creased risk of hospitalization for CD and UC in
drivers.
The potential protective role of physical activi-
ty in CD development, as well as the existence of
an inverse association between CD and physical
exercise, has also been supported by the results
of two large prospective cohort studies on US fe-
male nurses66. Compared with women in the low-
est fifth of overall physical activity, the age ad-
justed risk of CD decreased with increasing level
of exercise. Active women with at least 27 meta-
bolic equivalent task (MET) hours per week of
physical activity, or the equivalent of more than
nine hours per week of walking at an average
pace, had a 44% reduction in risk of developing
CD compared with sedentary women with <3
MET hours per week. Physical activity was not
associated with risk of UC. Consistently, Ng et
al67, examining environmental risk factors prior
to the development of IBD in a population-based
cohort in Asia-Pacific, found that daily exercise,
when compared with less frequent one, was pro-
tective for CD. Although the exact mechanism
for this association is not clear, physical activity
may induce autophagy and regulate innate immu-
nity to reduce chronic inflammation68.
As previously mentioned, caution should be
paid in interpreting the higher IBD prevalence in
sedentary-low physical demanding occupations,
because they may show an unduly high preva-
lence of disease not due to their hazardous influ-
ence but to their less demanding working condi-
tions attracting chronically affected IBD
workers18. Such potential bias may impress an ar-
tificial protection from IBD among more active
occupations while attributing an aggressive influ-
ence to more sedentary ones and, therefore, re-
quires to be carefully evaluated in prospective
epidemiological studies.
Organizational Risk Factors
Expansion of service sector, growing impact of
information technology, flexibility of employ-
ment arrangements have induced profound
changes in the nature of employment and work,
with consequent health adverse work time
arrangements affecting large part of the work-
force69. Therefore, it seems extremely important
to understand how work organizational character-
istics in modern economies can affect the health
of working people, with a specific attention on
those chronically affected by disabling illness.
Increased evidence has supported disrupted
sleep in shift workers as a risk factor for a num-
ber of gastrointestinal disorders70. As regards
IBD, Sonnenberg20 suggested that extended and
irregular shift work could be a risk for contract-
ing IBD as demonstrated by the most noticeable
increases in odds ratio determined in electricians,
technical assistants, bakers and female hair-
dressers. These occupations seem to exemplify
the working environments characterized by artifi-
cial lights, extended and irregular shifts, and in-
fringement of the normal diurnal rhythm. Con-
versely, Boggild et al64 in two register-based co-
hort studies on Danes IBD patients, failed to
demonstrate a relationship between non- daytime
jobs and hospitalization for IBD. Neither groups
with predominately night and morning work, late
evening work, and 24-hour services, nor groups
with other forms of irregular working hours had
an elevated risk of hospitalization. More recently,
Swanson et al71 reported that they clinically not-
ed a strong association between worsening of the
disease course in two UC patients, one police-
man and one female nurse, and one CD patient, a
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fire-woman, who started shift work and in two
patients with CD and multiple periods of jet lag
and an improvement when they returned to a nor-
mal schedule.
Although conflicting results emerged from
these studies and further occupational research
seems necessary, the biological plausibility that
disturbed sleep may be a modifiable behavioural
risk factor for IBD has been suggested by a series
of other studies72-74. CD patients with disturbed
sleep while in clinical remission had nearly dou-
ble the likelihood of disease flare at 6 months
compared with those with unimpaired sleep75.
Moreover, the totality of clinically active IBD pa-
tients studied by Ali et al76 revealed abnormal
sleep patterns. In animal models, acute or chron-
ic sleep deprivation increased susceptibility to
dextran sodium sulphate-induced colitis, a wide-
ly used mouse model of IBD77,78.
Altered sleep and sleep deprivation can nega-
tively affect gastrointestinal function, but has al-
so the potential to cause immune activation of
natural killer cells and monocytes and the release
of inflammatory cytokines such as tumor necro-
sis factor (TNF)-α and IL-6, thus, impacting dis-
ease course in gastrointestinal inflammatory dis-
orders like IBD9,71,79. Inflammatory processes can
in turn affect sleep pattern, with inflammatory
mediators such as TNF-α found to suppress
clock gene expression which are involved in reg-
ulating intestinal permeability and thus create a
vicious cycle and positive-feedback loop to
maintain and perpetuate inflammation71,80. More-
over, melatonin, which is important in the regula-
tion of circadian rhythms has been demonstrated
to be a powerful antioxidant and free radical
scavenger and has also been found to decrease
levels of TNF-α. The disregulation of melatonin
cycling production may act triggering these im-
portant pathways in IBD. These preliminary
studies give a rationale to proceed with future in-
vestigations examining the effects the disruption
of sleep/circadian homeostasis due to shift works
may have on disease course of IBD81.
With the advent of economic globalization,
stressful psychosocial work environments have
become even more important in terms of adverse
health effects69. IBD patients readily identify
stress as causing or triggering their disease82,83.
There is consistent evidence, in fact, that psycho-
logical factors may play a role both in the patho-
physiology and manifestations of IBD as well as
on the manner patients deal with their dis-
ease82,84,85. The physiological response to stress
involves a cascade of reactions through the so
called brain-gut axis. It starts from the hypothala-
mus, proceeds via the stimulation of the sympa-
thetic and parasympathetic nervous systems, and
communicates with the gut’s own rich nerve sup-
ply that controls gut motility and endocrine and
exocrine functions in the gastrointestinal
tract83,85,86.
However, it is difficult to establish a definite
causal relationship between stressful life events
and IBD considering also that once it develops,
the unpredictability, uncertainty and chronic
course of the disease itself can cause in turn a
wide range of personal, interpersonal and profes-
sional concerns requiring a complex, stressful
adaptive process83. Moreover, activation of a
stress response is highly dependent on the ap-
praisal of the circumstance as stressful which is
influenced by individual difference factors such
as coping strategies, life experience and personal
resources82.
Even more difficult is to understand the role of
work related stress in the disease development
and progression. In the early 1960s, Bonnevie10
reported that a greater percentage of UC civil ser-
vants and wage earners belonged to the senior
salaried grade and to the skilled labor group, re-
spectively, compared to the entire population of
the Copenhagen city district. These results could
be also interpreted according to the hypothesis
that occupational psychic strains, i.e. social striv-
ing and competition to get on, in the civil ser-
vants and salaried grades group, had the effect to
more frequently unmask diagnostically evident
UC, from a slightly inactive, subclinical form,
than in persons found in less ambitious socio-
economic strata.
More recently, as a part of the Manitoba IBD
cohort study, Rogala et al87 reported no signifi-
cant differences in the level of work-related
stress in IBD partecipants compared to a commu-
nity sample as control. Bernstein et al82 found
that IBD patients were more likely to have a ma-
jor stressful event occurring in the period before
the relapse compared to inactive patients. This
event was more commonly in the family/domes-
tic or less frequently in the personal health-relat-
ed stress categories.
Importantly, Heikkila et al88 conducted a meta-
analysis to investigate the association between
work-related stress and incidence of CD and UC
according to individual-level data obtained from
11 European studies with over 95000 parteci-
pants. Findings suggested that job strain, defined
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as high demands and low control at work, was
not a major risk factor for CD and UC. The Au-
thors pointed out that these findings did not take
away the cross-sectional evidence that IBD pa-
tients often experience stress, or that stress can
trigger symptoms and exacerbations in these dis-
eases. However, they underlined that the trigger-
effect was evident in studies in which the time
from the stressful event or experience to the on-
set of symptoms or diagnosis of IBD was rela-
tively short. As an occupational example, in-
creases in stress, anxiety, and depression as well
as pro-inflammatory immune activations and al-
terations in intestinal permeability, all factors
predisposing to IBD, were determined after a
short period (6 weeks), high-intensity combat
training course in Asian male soldiers89. The sev-
eral years of follow-up in Heikkila et al88 may be
essential for disentangling the possible impact of
job strain on the disease process. Importantly,
these findings may not be generalised to other in-
dicators of work-related stress or sources of
stress outside work. Further large, prospective,
population-based studies seem necessary to clari-
fy whether other operationalisations of work-re-
lated stress or stress in other areas of life have a
role in the aetiology of IBD.
Discussion
To the best of our knowledge, this review rep-
resents the first attempt to provide a comprehen-
sive evaluation of the possible role of specific oc-
cupational risk factors in the development and re-
lapse of IBD. This seems an intriguing topic
which goes to fill a gap in the scientific literature
concerning environmental epidemiology of this
disorder. Moreover, the increasing global burden
of IBD, its effects on patients’ quality of life and
ability to work, the impacts on the health care re-
sources and on the overall economic system due
also to the indirect costs of the disease based on
work loss and productivity reduction, clearly
make this issue a public health concern15,17,87,90-92.
Importantly, IBD can affect patients in their
early adulthood, an age when most people make
critical decisions regarding both their education
and career which in turn may affect the course of
their illness. IBD continues throughout the entire
life of patients, with a history characterized by
remissions and relapses, often requiring hospital-
izations and surgery, necessitating work absences
and disability. In this context, work may be a rel-
evant functioning area affected by IBD that re-
quires both patient’s efforts to participate in the
labor force as well as adequate programs of
risk/health management in workplaces. More-
over, with the aging of the active working popu-
lation, and considering the second smaller IBD
peak of incidence in subjects between 50 and 70
years, occupational physicians may find them-
selves to manage aged IBD employees to pursue
their expertise while facing occupational risks
and functional limitations.
Unfortunately, only a limited number of stud-
ies addressed the relationship between potential
dangerous occupational exposures and IBD, of-
ten with conflicting and quite fragmented results
that do not allow to extrapolate strong evidence
and definite conclusions. In fact, although some
studies have found increased risk for CD and UC
among people in certain occupational cate-
gories18,20,21,64, few have reported association be-
tween specific occupations and the incidence of
IBD. Therefore, uncertainty remains about direc-
tion of causality. This means that it is not yet
clearly defined if certain jobs pose risks for the
development of IBD or whether patients with
IBD choose particular occupations because of the
practical restrictions their illness presents19.
It is plausible that particular jobs can expose
workers to harmful agents, but most of the re-
viewed studies did not provide qualitative and
quantitative information in this regard as well as
details regarding job tasks performed by IBD
workers, thus preventing the identification of
specific occupational triggers for IBD induction
and relapse. Therefore, future cohort and case-
control studies should be focused to this aim,
particularly addressing the relationship between
workplace and job task features and disease clini-
cal phenotypes, activity and comorbidities. Great
stimulus in this direction may be provided by
early findings obtained from the general epi-
demiological research, which may be extrapolat-
ed to and specifically investigated in occupation-
al settings.
In this context, the environmental monitoring,
i.e. the periodic measurement of the level or con-
centration of a chemical, physical or biological
risk factor in the workplace, as an indirect mea-
sure of human exposure, should be routinely per-
formed to check the appropriateness of collective
and personal protective measures adopted to
avoid levels of exposure exceeding permissible
or recommended limits. Biological monitoring of
chemical or biochemical markers may be also an
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important instrument to assess the individual real
dose of exposure of IBD workers. An altered mu-
cosal permeability, in fact, may induce an over-
exposure to some xenobiotics, i.e. through an
easier gastrointestinal adsorption of substances
resulting from the mucociliary clearance of in-
haled particles, in case of accidental events or
when proper standards of personal and industrial
hygiene are not met. This overexposure may in
turn cause more severe health effects.
Furthermore, due to the potential interplay be-
tween genetic, personal habits, i.e dietary and
smoking habits, general environment and work-
place factors in affecting IBD, a global health
surveillance of patients in their workplace envi-
ronment should firstly include an accurate collec-
tion of anamnestic data. These may be compre-
hensive of information concerning physiological
and medical history, lifestyle and disease course
and features. Occupational history should be
gathered including performed jobs and duration
of employment as well as patient perceptions of
risks, difficulties and limitations at work, togeth-
er with accommodations thought necessary for a
more comfortable job. Moreover, as epidemio-
logical evidence becomes more substantial, as in
the case of sleep impairment and disease relapse,
the assessment of certain organizational aspects
of jobs, i.e. shift-works, should become routinely
assessed in IBD care75. Physical examination, al-
so looking for extra-intestinal disabling manifes-
tations93,94 and laboratory studies including the
evaluation of early biomarkers of disease activity,
appear essential to identify early signs of relapse
as well as to define those risk factors for which
IBD patients may be more susceptible.
The identification of susceptibility to certain
job risk factors seems essential to ascertain IBD
fitness for work. However, current evidence is
not so strong as to conclude that some agents are
or are not dangerous for IBD or that certain jobs
can be continued or not. In this context, future
epidemiological research should firstly clarify if
the greater prevalence of IBD in certain occupa-
tions is effectively related to their intrinsic char-
acteristics, i.e. if inactive working life can nega-
tively affect IBD, or whether it depends on the
selection bias due to the forced choice of less
physical demanding activities due to IBD related
functional limitations and fatigue95. Particularly,
concerning the protective role of physical activity
on IBD, the statement “more physical workload
can be better” may be argued62. However, a care-
ful evaluation of the possible adverse health ef-
fects induced by excessively stressing conditions
of posture, biomechanical strain, force, lack of
recovery and combinations of these exposures, as
components of physical workload, should be per-
formed to define a correct management of IBD
on work.
Medical treatment should be also considered
for its role in modifying susceptibility to occu-
pational exposures. Immunosuppressive actions
of IBD drugs, such as azathioprine and mercap-
topurine, as well as monoclonal antibodies are
associated with an increased risk of potentially
life-threathening infectious and malignant com-
plications96-101, thus probably making IBD work-
ers more susceptible to the toxic action of bio-
logical as well as mutagenic or genotoxic chemi-
cal agents. Occupational epidemiological studies
in this regard may be important to define the
possibility for an IBD patient to remain long-
term employed in particular professions. Consis-
tently, research efforts in radiological protection
should define the role that occupational expo-
sure to ionizing radiations may play in enhanc-
ing risk for tumor development in IBD patients.
This seems important, particularly for IBD
workers with a more severe disease who undergo
multiple x-ray diagnostic imaging procedures
and require a more frequent use of immunosup-
pressive and/or biological drugs102,103. As an ulte-
rior example, thiopurines photosensitize human
skin to UVA radiation1. This sensitivity has been
associated with an increased risk of non
melanoma skin cancer in CD and requires pro-
tection against UVA and long-life dermatological
surveillance104. Therefore, also the beneficial an-
ti-inflammatory action exerted by UV radiation
should be carefully contextualized in a case by
case evaluation.
Overall, a deeper comprehension of the occu-
pational factors involved in the causative IBD
pathways and, in turn, of the effects that the dis-
ease may exert on patients’ job quality and pro-
ductivity may help to define the “healthy IBD
patterns of work”. These may include the identi-
fication of healthy levels of exposure, frequen-
cies and durations, in respect of requirements and
conditions in each specific occupation and com-
pany, with the due attention to the needs of the
individual IBD employee. This may lead general
practitioners, health care specialists, and occupa-
tional physicians to recognise modifiable work-
place factors, to plan preventive and protective
measures and to propose patients lifestyle and
treatment actions to obtain a well-integrated and
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successful disease management, while improving
their well-being at work. In this context, the con-
certed action of all the prevention figures of the
company, including employers, with the coopera-
tion of the same IBD workers, according to an
empowerment perspective, should be strongly
encouraged105,106.
Therefore, workers should be aware of their
disorder, the possible consequences on work as
well as of work-related problems and barriers
and they should also be provided with informa-
tion and training concerning the coping skills and
social competences necessary to face them. Con-
sidering that what is more striking for IBD pa-
tients is the sense they have that they are not
“keeping up” at work and have to reduce their
activities87, interventions aimed to give them ade-
quate measures of control for job demand, to-
gether with the support from colleagues and
managers and the appropriate organizational fea-
tures, may be important to reduce job strain, per-
ceived job discrimination and disability outcome.
All these actions may help workers to retain their
jobs and work pleasure, to increase feelings of
self confidence or self efficacy in dealing with
work-related problems, practical solutions and
accommodations having in turn positive effects
on their general health status.
Conclusions
Environmental factors are essential compo-
nents in the pathogenesis of IBD. However, the
potential role played by chronic occupational ex-
posures in affecting the development and pro-
gression of CD and UC has not been clearly un-
derstood. Therefore, specific exposures to groups
of potential workplace hazardous agents have
been reviewed with the aim to define how certain
jobs may pose risks for IBD and to describe pos-
sible underlined mechanisms of action. Unfortu-
nately, a limited number of studies addressed this
issue and uncertainty still remains regarding the
affecting role of chemical and biological agents,
the health effects of ionizing or non- ionizing ra-
diation exposure, the possible consequences of
shift-works, indoor, and sedentary works as well
as job strain on IBD. However, critical points of
discussion emerged which may give stimulus to
future epidemiological research aimed to clarify
the complex interplay between occupational risk
factors and IBD course and, in turn, between
IBD functional limitations and fitness for work.
In this scenario, occupational causative path-
ways for disease development and relapse, dan-
gerous conditions of exposure, susceptibility to
specific workplace risk factors according to IBD
phenotype, comorbidities and treatment fol-
lowed, as well as the consequences of the mor-
bidity restrictions on career choice and expecta-
tions, ability to work, productivity and well-be-
ing should be carefully investigated. From a pub-
lic health perspective this seems absolutely im-
portant considering the increasing global burden
of IBD, especially in working-age adults, its con-
sequences on patients’ quality of life and ability
to work as well as the impact on the health care
resources. Although a certainly challenging is-
sue, a more comprehensive knowledge may
guide concerted actions of health care providers,
occupational physicians, and employers together
with IBD workers to plan preventive and protec-
tive measures for “healthy IBD patterns of work”
and to develop innovative perspectives for an in-
tegrated management of IBD workers in differ-
ently hazardous occupational settings. All these
actions may improve the quality of patients’
working life, providing them coping skills, social
competences and support to face job tasks and
possible work related problems.
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